North America
Alnylam Joins Illumina and NashBio’s Alliance for Genomic Discovery
Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicines Members levera...
September 19, 2025 | News
Roche Wins First CLIA ‘Moderate Complexity’ Designation for Mass Spectrometry Vitamin D Test
First mass spectrometry-based test system for total 25-Hydroxyvitamin D to receive CLIA 'Moderate Complexity' designation in the U.S....
September 19, 2025 | News
Mikart and Nano PharmaSolutions Report Positive Phase 1 Data for NT-301 in Parkinson’s Disease
Mikart, LLC, a leading contract development and manufacturing organization (CDMO), and Nano PharmaSolutions, Inc. (NPS), a nanodrug delivery pharmaceutical...
September 19, 2025 | News
Mabwell and Aditum Bio Launch Kalexo Bio with $1 Billion siRNA Deal for Dyslipidemia and ASCVD
Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio announced the launch of Kalexo Bio, a new company formed in conjunction with an exc...
September 18, 2025 | News
Johnson & Johnson’s Amivantamab–Lazertinib Combo Extends Survival Beyond Four Years in Asia NSCLC Cohort
Median overall survival in Asia cohort is projected to exceed four years, demonstrating a durable benefit and surpassing osimertinib monotherapy by more th...
September 17, 2025 | News
Eli Lilly to Invest $5 Billion in New Virginia API and Bioconjugate Manufacturing Facility
New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other ad...
September 17, 2025 | News
US, China and Australia Begin Phase 2 Trial of Atom Therapeutics’ ABP-745 for Acute Gout Flares
ABP-745 is an oral small molecule drug with potential applications, for other inflammatory conditions such as cardiovascular disease Atom T...
September 17, 2025 | News
Biostar Pharma Doses First Patients in Two Global Phase II/III Trials of Oral Utidelone Capsule for Gastric and Ovarian Cancers
Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biolo...
September 16, 2025 | News
Rona Therapeutics Submits RN3161 to Australian HREC as INHBE-Targeting GalNAc siRNA for Obesity
Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced the successful submission of RN3161 to the Australian Human R...
September 16, 2025 | News
LabConnect and OmniScience Partner to Launch Industry’s First AI Control Tower for Clinical Trial Lab Data
Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. -- LabConn...
September 16, 2025 | News
Thermo Fisher Scientific Introduces Gibco™ Efficient-Pro™ Medium (+) Insulin to Boost Titers by Up to 61% and Streamline Bioproduction
Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines Thermo Fisher Sci...
September 16, 2025 | News
DHL Supply Chain Expands Healthcare Footprint with Acquisition of SDS Rx
Acquisition will add long-term care and specialty pharmacies, radiopharmacies, and health system networks to DHL Supply Chain’s life sciences and h...
September 15, 2025 | News
Pulnovo Medical Secures Dual FDA IDE Approvals and CMS Coverage for PADN Clinical Trials in the U.S.
Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN...
September 15, 2025 | News
B. Braun Acquires True Digital Surgery to Accelerate Innovation in 3D Robotic Microsurgery
Acquisition to Enhance Technological Advancements and Expand Market Share in Digital Microsurgery B. Braun SE, a leading medical technology company,...
September 15, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
